This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Neurogenetics  • Alert me on articles by topic  Social Bookmarking   What's this?

Suzuka Ataka, MD; Takami Tomiyama, PhD; Hiroshi Takuma, MD, PhD; Takenari Yamashita, MS; Hiroyuki Shimada, MD, PhD; Tsuyoshi Tsutada, MD, PhD; Koichi Kawabata, MD; Hiroshi Mori, PhD; Takami Miki, MD, PhD

Arch Neurol. 2004;61:1773-1776.

Background  Early-onset familial Alzheimer disease is caused by mutations in the amyloid precursor protein (APP), presenilin-1 (PSEN1), or presenilin-2 (PSEN2) genes. Phenotypic diversity has been reported to be associated with various mutations in PSEN1. Various mutations of PSEN1 have been reported in cases of early-onset Alzheimer disease with spastic paraparesis.

Objective  To describe a novel mutation in the PSEN1 gene associated with early-onset Alzheimer disease with spastic paraparesis.

Patient and Methods  The patient was a 27-year-old man who developed early-onset dementia with spastic paraparesis. We examined sequences of the PSEN1, PSEN2, and APP genes from the patient and his family. To detect a possible mutation effect on the production of amyloid- peptide (A), transfected HEK293 cells were examined for A42 and A40 production.

Results  We found a novel mutation (Leu85Pro) in PSEN1. This mutation influenced the production of A, resulting in a 2-fold elevation of A42 production and of the A42/40 ratio.

Conclusion  To our knowledge, this is the first report of very early–onset Alzheimer disease with spastic paraparesis and with the visual variant form of the disease, which is associated with visuospatial cognitive disorder. The Leu85Pro mutation in PSEN1 was pathogenic.

Author Affiliations: Departments of Neurology (Drs Ataka, Shimada, Tsutada, Kawabata, and Miki) and Neuroscience (Drs Tomiyama, Takuma, and Mori andMr Yamashita), Osaka City University Medical School, Osaka, Japan.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Novel Presenilin 1 Mutation (S170F) Causing Alzheimer Disease With Lewy Bodies in the Third Decade of Life
Snider et al.
Arch Neurol 2005;62:1821-1830.
ABSTRACT | FULL TEXT